Optometrists in Greenwood, MS Accepting Medicare
6 Optometrists found. Showing 1 - 6
 Greenwood Eye Care, Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2202 Hwy 82 W, Greenwood, MS 38930 Phone: 662-609-6402 |
 Dr. Forrest Walker Manning, O.D. Optometrist Medicare: May Accept Medicare Assignments Practice Location: 2202 Highway 82 W, Greenwood, MS 38930 Phone: 662-455-7840 Fax: 662-455-7841 |
Manning Eye Care Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2202 Hwy 82 West, Greenwood, MS 38930 Phone: 662-455-7840 Fax: 662-455-7841 |
Todd Hall Od Pa Optometrist Medicare: Medicare Enrolled Practice Location: 814 W Park Ave, Greenwood, MS 38930 Phone: 662-453-5400 Fax: 662-453-5726 |
Dr. Jacob Daniel Long, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2202 Hwy 82 West, Greenwood, MS 38930 Phone: 662-609-6402 |
Todd Hall, O.D. Optometrist Medicare: May Accept Medicare Assignments Practice Location: 814 W Park Ave, Greenwood, MS 38930 Phone: 662-453-5400 Fax: 662-453-5726 |
News Archive
Takeda announces submission of azilsartan medoxomil NDA for hypertension to FDA
Takeda Pharmaceutical Company Limited (Takeda) announced today that Takeda Global Research & Development Center, Inc., U.S., submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for azilsartan medoxomil (development code: TAK-491), an angiotensin II receptor blocker (ARB) under investigation for the treatment of hypertension. Discovered by Takeda, azilsartan medoxomil is designed to lower blood pressure by blocking the action of a vasopressor hormone, angiotensin II.
AASLD publishes updated practice guidelines on hepatitis C
On Monday, September 26, 2011, the American Association for the Study of Liver Diseases published online at its journal Hepatology's website an update to its practice guidelines for hepatitis C – "An Update on Treatment of Genotype 1 Chronic Hepatitis C Virus Infection: 2011 Practice Guideline by the American Association for the Study of Liver Diseases."
IMS supports new guidance on glucocorticoid use
The International Osteoporosis Foundation, along with the European Society for Calcified Tissue, launched new guidance on glucocorticoid use at the European Congress on Osteoporosis and Osteoarthritis (which took place in Bordeaux from March 21 - 24, 2012). Given the special relevance to postmenopausal women, the International Menopause Society (IMS) is supporting the publication of the guidance.
HIV prevention program undergoes "real world" evaluation
A programme that provides pre-exposure prophylaxis (PrEP) to prevent HIV infection among sexually active gay men has not seen one case of HIV infection since it began in 2012, according to the first "real world" evaluation of the regimen at Kaiser Permanente San Francisco Medical Center.
› Verified 6 days ago
Physical Therapists
Chiropractors
Occupational Therapists
Optometrists
Podiatrists
Speech-Language Pathologists